These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7062254)

  • 21. Binding of phenylbutazone to human serum albumin. Characterization and identification of binding sites.
    Russeva V; Mihailova D
    Arzneimittelforschung; 1999 Mar; 49(3):255-8. PubMed ID: 10219470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of the interaction of phenylbutazone, oxyphenbutazone and methandrostenolone in man.
    Hvidberg EF; Dayton PG; Read JM; Wilson CH
    Proc Soc Exp Biol Med; 1968 Nov; 129(2):438-43. PubMed ID: 5696765
    [No Abstract]   [Full Text] [Related]  

  • 23. Binding of pirprofen to human serum albumin studied by dialysis and spectroscopy techniques.
    Otagiri M; Masuda K; Imai T; Imamura Y; Yamasaki M
    Biochem Pharmacol; 1989 Jan; 38(1):1-7. PubMed ID: 2910295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
    Spahn H; Mutschler E; Geissler HE; Faust-Tinnefeldt G
    Arzneimittelforschung; 1981; 31(3):499-503. PubMed ID: 6894380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Azapropazone binding to human serum albumin.
    Fehske KJ; Jähnchen E; Müller WE; Stillbauer A
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):159-63. PubMed ID: 7422015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of some physico-chemical properties of human serum albumin samples from different sources--II. The characteristics of the N-B transition and the binding behaviour with regard to warfarin and diazepam.
    Dröge JH; Wilting J; Janssen LH
    Biochem Pharmacol; 1982 Dec; 31(23):3781-6. PubMed ID: 7159460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Participation of the lone tryptophan residue of rat alpha-foetoprotein in its drug-binding sites. Comparison with rat serum albumin.
    Hervé F; Martin MT; Rajkowski K; Dessen P; Cittanova N
    Biochem J; 1987 May; 244(1):81-5. PubMed ID: 2444212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human serum albumin conformational changes as induced by tenoxicam and modified by simultaneous diazepam binding.
    Brée F; Urien S; Nguyen P; Tillement JP; Steiner A; Vallat-Molliet C; Testa B; Visy J; Simonyi M
    J Pharm Pharmacol; 1993 Dec; 45(12):1050-3. PubMed ID: 7908973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of kebuzone to human serum albumin studied by high performance liquid affinity chromatography.
    Zhivkova ZD; Russeva VN
    Arzneimittelforschung; 2000 Mar; 50(3):272-5. PubMed ID: 10758780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug interactions. II. Binding of some pyrazolone and pyrazolidine derivatives to bovine serum albumin.
    Ozeki S; Tejima K
    Chem Pharm Bull (Tokyo); 1974 Jun; 22(6):1297-301. PubMed ID: 4472458
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxyphenbutazone and phenylbutazone determination in plasma and urine by GLC.
    Bruce RB; Maynard WR; Dunning LK
    J Pharm Sci; 1974 Mar; 63(3):446-8. PubMed ID: 4820382
    [No Abstract]   [Full Text] [Related]  

  • 33. Study of the binding of antibiotics to human serum albumin by charge-transfer chromatography.
    Cserháti T; Forgács E
    J Chromatogr A; 1997 Jul; 776(1):31-6. PubMed ID: 9286075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
    Kragh-Hansen U
    Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A chronic dose-ranging study of the pharmacokinetics of phenylbutazone in rheumatoid arthritic patients.
    Higham C; Aarons L; Holt PJ; Lynch M; Rowland M
    Br J Clin Pharmacol; 1981 Aug; 12(2):123-9. PubMed ID: 7306426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of tobacco on the serum levels and pharmacokinetics of phenylbutazone and oxyphenbutazone].
    Queneau P; Ollagnier M; Decousus H; Perpoint B; Brazier JL; Faucon L
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):293-7. PubMed ID: 6879097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circular dichroic examination of the interaction of some planar acidic drugs with tryptophan-modified human serum albumin.
    Vallner JJ; Perrin JH
    J Pharm Pharmacol; 1981 Nov; 33(11):697-700. PubMed ID: 6171635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of teicoplanin to human serum albumin.
    Assandri A; Bernareggi A
    Eur J Clin Pharmacol; 1987; 33(2):191-5. PubMed ID: 2961570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the tryptophan and drug-binding properties of human serum albumin fragments by affinity chromatography and circular dichroism measurements.
    Sjöholm I; Ljungstedt I
    J Biol Chem; 1973 Dec; 248(24):8434-41. PubMed ID: 4148670
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in miniature donkeys.
    Matthews NS; Peck KE; Taylor TS; Mealey KL
    Am J Vet Res; 2001 May; 62(5):673-5. PubMed ID: 11341383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.